Abstract
Resistance to chemotherapy ('drug resistance') is a fundamental problem that limits the effectiveness of many chemotherapies currently used to treat cancer. Drug resistance can occur due to a variety of mechanisms, such as increased drug inactivation, drug efflux from cancer cells, enhanced repair of chemotherapy-induced damage, activation of pro-survival pathways and inactivation of cell death pathways. In this article, we review some of the major mechanisms of drug resistance and discuss how new molecularly-targeted therapies are being increasingly used to overcome these resistance mechanisms.
Original language | English |
---|---|
Pages (from-to) | 5138-5154 |
Number of pages | 17 |
Journal | Frontiers in Biosciences |
Volume | 13 |
Issue number | 13 |
DOIs | |
Publication status | Published - 2008 |
ASJC Scopus subject areas
- General Biochemistry,Genetics and Molecular Biology
- Biochemistry
- Cell Biology